Veterinary Medicines

Frontline Spot On Cat

Authorised
  • Fipronil
Download as PDF

Product identification

Medicine name:
Frontline Spot On Cat
Active substance:
  • Fipronil
Target species:
  • Cat
Route of administration:
  • Topical use

Product details

Active substance and strength:
  • Fipronil
    10.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX15
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Heatformed shell containing an extractable volume of 0.5ml: double foiled film composed of polypropylene and a copolymer of olyacrylonitrile-methacrylate in contact with the solution (200 µm /350 µm).Opercule: triple foiled film composed of polyethylene terphthalate opacified with titanium dioxide, aluminium and a copolymerof olyacrylonitrile-methacrylate in contact with the solution (12 µm/12 µm /35 µm).Presented in cartons containing 12 pipettes.
  • Heatformed shell containing an extractable volume of 0.5ml: double foiled film composed of polypropylene and a copolymer of olyacrylonitrile-methacrylate in contact with the solution (200 µm /350 µm).Opercule: triple foiled film composed of polyethylene terphthalate opacified with titanium dioxide, aluminium and a copolymerof olyacrylonitrile-methacrylate in contact with the solution (12 µm/12 µm /35 µm).Presented in cartons containing 9 pipettes.
  • Heatformed shell containing an extractable volume of 0.5ml: double foiled film composed of polypropylene and a copolymer of olyacrylonitrile-methacrylate in contact with the solution (200 µm /350 µm).Opercule: triple foiled film composed of polyethylene terphthalate opacified with titanium dioxide, aluminium and a copolymerof olyacrylonitrile-methacrylate in contact with the solution (12 µm/12 µm /35 µm).Presented in cartons containing 6 pipettes.
  • Heatformed shell containing an extractable volume of 0.5ml: double foiled film composed of polypropylene and a copolymer of olyacrylonitrile-methacrylate in contact with the solution (200 µm /350 µm).Opercule: triple foiled film composed of polyethylene terphthalate opacified with titanium dioxide, aluminium and a copolymerof olyacrylonitrile-methacrylate in contact with the solution (12 µm/12 µm /35 µm).Presented in blister cards containing 3 pipettes, and cartons containing 3 pipettes.
  • Heatformed shell containing an extractable volume of 0.5ml: double foiled film composed of polypropylene and a copolymer of olyacrylonitrile-methacrylate in contact with the solution (200 µm /350 µm).Opercule: triple foiled film composed of polyethylene terphthalate opacified with titanium dioxide, aluminium and a copolymerof olyacrylonitrile-methacrylate in contact with the solution (12 µm/12 µm /35 µm).Presented in blister cards containing 1 pipette.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10454/048/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download